Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Ebiomedicine
|
May 24, 2016
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
Urmi Sengupta, Ashley N Nilson, Rakez Kayed
Trends in Pharmacological Sciences
|
August 20, 2023
Dopamine receptor divergence revealed using a common ligand
David R Sibley, Ashley N Nilson, Amy E Moritz, et al.
Biorxiv : the Preprint Server for Biology
|
April 25, 2024
Functionally selective dopamine D1 receptor endocytosis and signaling by catechol and non-catechol agonists
Ashley N Nilson, Daniel E Felsing, Pingyuan Wang, et al.
Biochemistry
|
March 20, 2025
Functionally Selective Dopamine D1 Receptor Endocytosis and Signaling by Catechol and Noncatechol Agonists
Ashley N Nilson, Daniel E Felsing, Pingyuan Wang, et al.
Journal of Alzheimer'S Disease : JAD
|
October 8, 2016
Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases
Ashley N Nilson, Kelsey C English, Julia E Gerson, et al.
RSC Advances
|
July 13, 2026
Synthesis and systematic evaluation of four stereoisomers of BMS compound A enabled by a diastereoselective cyclopropanation on a chiral ketal intermediate
Feijun Wang, John N Hanson, Snezana T Dimova, et al.
Aging and Disease
|
June 6, 2017
Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related Tauopathies
Diana L Castillo-Carranza, Ashley N Nilson, Candice E Van Skike, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Multiple Allosteric Sites Allow for Synergistic Enhancement of GPCR Signaling
Kai Wang, Snezana T Dimova, John N Hanson, et al.
ACS Pharmacology & Translational Science
|
January 19, 2023
Identification and Characterization of ML321: A Novel and Highly Selective D<sub>2</sub> Dopamine Receptor Antagonist with Efficacy in Animal Models That Predict Atypical Antipsychotic Activity
R Benjamin Free, Ashley N Nilson, Noelia M Boldizsar, et al.
ACS Pharmacology & Translational Science
|
February 19, 2026
Bioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand Pharmacokinetics
Mohammad Alkhatib, Franziska M Jakobs, John N Hanson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Ebiomedicine
|
May 24, 2016
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
Urmi Sengupta, Ashley N Nilson, Rakez Kayed
Trends in Pharmacological Sciences
|
August 20, 2023
Dopamine receptor divergence revealed using a common ligand
David R Sibley, Ashley N Nilson, Amy E Moritz, et al.
Biorxiv : the Preprint Server for Biology
|
April 25, 2024
Functionally selective dopamine D1 receptor endocytosis and signaling by catechol and non-catechol agonists
Ashley N Nilson, Daniel E Felsing, Pingyuan Wang, et al.
Biochemistry
|
March 20, 2025
Functionally Selective Dopamine D1 Receptor Endocytosis and Signaling by Catechol and Noncatechol Agonists
Ashley N Nilson, Daniel E Felsing, Pingyuan Wang, et al.
Journal of Alzheimer'S Disease : JAD
|
October 8, 2016
Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases
Ashley N Nilson, Kelsey C English, Julia E Gerson, et al.
RSC Advances
|
July 13, 2026
Synthesis and systematic evaluation of four stereoisomers of BMS compound A enabled by a diastereoselective cyclopropanation on a chiral ketal intermediate
Feijun Wang, John N Hanson, Snezana T Dimova, et al.
Aging and Disease
|
June 6, 2017
Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related Tauopathies
Diana L Castillo-Carranza, Ashley N Nilson, Candice E Van Skike, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Multiple Allosteric Sites Allow for Synergistic Enhancement of GPCR Signaling
Kai Wang, Snezana T Dimova, John N Hanson, et al.
ACS Pharmacology & Translational Science
|
January 19, 2023
Identification and Characterization of ML321: A Novel and Highly Selective D<sub>2</sub> Dopamine Receptor Antagonist with Efficacy in Animal Models That Predict Atypical Antipsychotic Activity
R Benjamin Free, Ashley N Nilson, Noelia M Boldizsar, et al.
ACS Pharmacology & Translational Science
|
February 19, 2026
Bioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand Pharmacokinetics
Mohammad Alkhatib, Franziska M Jakobs, John N Hanson, et al.
Page
of 2